Veterinärmedizinische Universität Wien Forschungsinformationssystem VetDoc

Grafischer Link zur Startseite der Vetmeduni Vienna

Rom Rita,

** = Publikationen gelistet in SCI/SSCI/Pubmed

2019

Zeitschriftenaufsatz

** Gawish, R; Bulat, T; Biaggio, M; Lassnig, C; Bago-Horvath, Z; Macho-Maschler, S; Poelzl, A; Simonović, N; Prchal-Murphy, M; Rom, R; Amenitsch, L; Ferrarese, L; Kornhoff, J; Lederer, T; Svinka, J [and 9 others] (2019): Myeloid Cells Restrict MCMV and Drive Stress-Induced Extramedullary Hematopoiesis through STAT1. Cell Rep. 2019; 26(9):2394-2406.e5
Open Access Logo

2016

Kongressbeitrag in einer Zeitschrift

** Poelzl, A; Prchal-Murphy, M; Gawish, R; Rom, R; Lassnig, C; Mueller, M; Strobl, B (2016): Kinase Dependent- and Independent Functions of Tyrosine Kinase 2 (TYK2) During Endotoxemia. 8th Congress of the International-Federation-of-Shock-Societies, Tokyo, JAPAN, Japan, OCT 03-05, 2016. Shock (46), 4 S2 64-64.

Publizierter (zitierfähiger) Beitrag für wissenschaftliche Veranstaltung in Proceedings (A2)

Gawish, R; Biaggio, M; Lassnig, C; Bago-Horvath, Z; Rom, R; Amenitsch, L; Kornoff, J; Bokor, M; Krmpotic, A; Sonjic, S; Strobl, B; Müller, M (2016): Myeloid interferon signaling protects from murine CMV infection and promotes extramedullary hematopoiesis. -EMDS 2016; SEP 21-23, 2016; Amsterdam, Netherlands.

Pölzl, A; Prchal-Murphy, M; Gawish, R; Rom, R; Lassnig, C; Müller, M; Strobl, B (2016): Kinase dependent and independent functions of tyrosine kinase 2 (TYK2) during endotoxemia. -The 8th Congress of the International Federation of Shock Societies - International Shock Congress 2016 Tokyo; OCT 3-5, 2016; Tokyo, JAPAN.

2015

Kongressbeitrag in einer Zeitschrift

** Poelzl, A; Prchal-Murphy, M; Rom, R; Kaufmann, T; Lassnig, C; Mueller, M; Strobl, B (2015): Kinase-independent functions of Tyrosine kinase 2 (Tyk2) contribute to the pathogenesis of lipopolysaccharide (LPS)-induced endotoxemia. 3rd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS), Bamberg, GERMANY, Germany, OCT 11-14, 2015. Cytokine (76), 1 90-90.

2014

Zeitschriftenaufsatz

** Leitner, NR; Lassnig, C; Rom, R; Heider, S; Bago-Horvath, Z; Eferl, R; Müller, S; Kolbe, T; Kenner, L; Rülicke, T; Strobl, B; Müller, M (2014): Inducible, dose-adjustable and time-restricted reconstitution of STAT1 deficiency in vivo. PLoS One. 2014; 9(1):e86608
Open Access Logo

** Vielnascher, RM; Hainzl, E; Leitner, NR; Rammerstorfer, M; Popp, D; Witalisz, A; Rom, R; Karaghiosoff, M; Kolbe, T; Müller, S; Rülicke, T; Lassnig, C; Strobl, B; Müller, M (2014): Conditional ablation of TYK2 in immunity to viral infection and tumor surveillance. Transgenic Res. 2014; 23(3):519-529

Publizierter (zitierfähiger) Beitrag für wissenschaftliche Veranstaltung in Proceedings (A2)

Biaggio, M; Lassnig, C; Rom, R; Krmpotic, A; Jonjic, S; Strobl, B; Müller, M (2014): STAT1 in myeloid cells is required to limit early replication of murine cytomegalovirus and its persistence in salivary glands. -10th YSA-Workshop of the Young Scientist Association (YSA); Juni 11-12, 2014; Medical University of Vienna (MUW Vienna).

Biaggio, M; Lassnig, C; Rom, R; Krmpotic, A; Jonjic, S; Strobl, B; Müller, M (2014): STAT1 in myeloid cells is required to limit early replication and persistence of murine cytomegalovirus in vivo. -28th International Conference of the EMDS ; OKT 2-4, 2014; Vienna, Austria.

2013

Kongressbeitrag in einer Zeitschrift

** Biaggio, M; Lassnig, C; Reichart, U; Rom, R; Krmpotic, A; Jonjici, S; Strobl, B; Müller, M (2013): The role of STAT1 in macrophages/neutrophils in the response to murine cytomegalovirus infection. Annual Joint Conference of the International-Cytokine-Society and the International-Society-for-Interferon-and-Cytokine-Research, San Francisco, USA, United States, SEP 29-OCT 03, 2013. Cytokine (63), 3 248-248.

2011

** Stiefvater, R; Vielnascher, RM; Hofmann, E; Reichart, U; Kolbe, T; Gerner, W; Popp, D; Vogl, C; Karaghiosoff, M; Müller, M; Strobl, B (2011): Conditional knockout of tyrosine kinase 2 (Tyk2): dissecting cell type-specific functions in innate IL-17 production. 9th Joint Meeting of the International-Cytokine-Society/International-Society-for-Interferon-and-Cytokine-Research, Florence, ITALY, Italy, OCT 09-12, 2011. Cytokine (56), 1 90-90.

Publizierter (zitierfähiger) Beitrag für wissenschaftliche Veranstaltung in Proceedings (A2)

Stiefvater, R; Vielnascher, RM; Hofmann, E; Reichart, U; Kolbe, T; Gerner, W; Popp, D; Vogl, C; Karaghiosoff, M; Müller, M; Strobl, B (2011): Conditional knockout of tyrosine kinase 2 (Tyk2): dissecting cell type-specific functions in innate IL-17 production. -9th Joint Meeting of the ICS/ISICR; Okt 9-12, 2011; Florence, Italy.

2010

Zeitschriftenaufsatz

** Radwan, M; Stiefvater, R; Grunert, T; Sharif, O; Miller, I; Marchetti-Deschmann, M; Allmaier, G; Gemeiner, M; Knapp, S; Kovarik, P; Müller, M; Strobl, B (2010): Tyrosine kinase 2 controls IL-1ß production at the translational level. J Immunol. 2010; 185(6):3544-3553
Open Access Logo

** Vogl, C; Flatt, T; Fuhrmann, B; Hofmann, E; Wallner, B; Stiefvater, R; Kovarik, P; Strobl, B; Müller, M (2010): Transcriptome analysis reveals a major impact of JAK protein tyrosine kinase 2 (Tyk2) on the expression of interferon-responsive and metabolic genes. BMC Genomics. 2010; 11:199
Open Access Logo

Kongressbeitrag in einer Zeitschrift

** Stiefvater, R; Hofmann, E; Kolbe, T; Reichart, U; Lassnig, C; Vogl, C; Poli, V; Müller, M; Strobl, B (2010): TYK2 is required for IL-17 production by innate immune cells in response to IPS. 8th Joint Conference of the International-Cytokine-Society/International-Society-for-and-Cytokine-Research, Chicago, IL, OCT 03-07, 2010. Cytokine (52), 1-2 31-31.

2008

** Stiefvater, R; Strobl, B; Hofmann, E; Kolbe, T; Reichart, U; Lassnig, C; Vogl, C; Poli, V; Müller, M (2008): Type I interferon-independent requirement of Tyk2 for LPS-mediated IL-17 expression in murine macrophages. Joint Annual Meeting of Immunology of the Austrian and German Societies (ÖGAI, DGfI), Vienna, Austria, Austria, September 3–6, 2008. Wien Klin Wochenschr (120), Suppl. 88-88.

© Veterinärmedizinische Universität Wien Hilfe und DownloadsErklärung zur Barrierefreiheit